West Drayton, United Kingdom

Paul D Hallam

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul D Hallam. Retrieved from https://idiyas.com/inventor/paul-d-hallam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul D Hallam

Introduction

Paul D Hallam is a notable inventor based in West Drayton, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporins. His work has led to advancements that benefit the medical community and patients alike.

Latest Patents

One of Hallam's key patents is for 3-(Optionally substituted-but-1-en-3-ynyl) cephalosporins. This patent involves compounds of general formula I, where R represents NH₂ or an acylated or silylated amino group. This innovation showcases his expertise in creating effective pharmaceutical compounds.

Career Highlights

Hallam is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on developing new and improved medications. His dedication to research and innovation has made a lasting impact on the field.

Collaborations

Throughout his career, Hallam has collaborated with notable colleagues, including Richard Bell and Michael W Foxton. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise.

Conclusion

Paul D Hallam's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…